Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in a research report issued to clients and investors on Monday. They currently have a $1,060.00 price target on the medical equipment provider’s stock. Wedbush’s price target points to a potential upside of 2.76% from the company’s previous close.

Other equities research analysts have also issued reports about the company. Royal Bank Of Canada reaffirmed a “hold” rating and set a $333.33 target price on shares of Intuitive Surgical in a research report on Friday, July 21st. Vetr lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $335.50 target price for the company. in a research report on Wednesday, August 16th. Citigroup Inc. reaffirmed a “buy” rating and set a $359.33 target price (up from $305.67) on shares of Intuitive Surgical in a research report on Monday, July 24th. Canaccord Genuity reaffirmed a “hold” rating and set a $290.00 target price on shares of Intuitive Surgical in a research report on Tuesday, July 11th. Finally, Bank of America Corporation reaffirmed a “buy” rating and set a $333.33 target price on shares of Intuitive Surgical in a research report on Thursday, June 1st. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $411.32.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 20th. The medical equipment provider reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.05. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The firm had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. During the same period last year, the firm posted $1.87 EPS. The business’s revenue was up 12.8% compared to the same quarter last year.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/09/25/intuitive-surgicals-isrg-outperform-rating-reiterated-at-wedbush.html.

In other news, VP Jamie Samath sold 242 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $949.01, for a total transaction of $229,660.42. Following the completion of the sale, the vice president now owns 23 shares in the company, valued at approximately $21,827.23. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark J. Meltzer sold 500 shares of Intuitive Surgical stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $1,025.00, for a total value of $512,500.00. Following the sale, the senior vice president now owns 2,796 shares of the company’s stock, valued at approximately $2,865,900. The disclosure for this sale can be found here. Insiders have sold a total of 23,172 shares of company stock valued at $21,923,487 in the last ninety days. Insiders own 2.20% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Guardian Life Insurance Co. of America boosted its position in shares of Intuitive Surgical by 2.2% during the 1st quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 3 shares during the last quarter. ETF Managers Group LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $110,000. D. Scott Neal Inc. bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $120,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $120,000. Finally, Parallel Advisors LLC boosted its position in shares of Intuitive Surgical by 10.1% during the 1st quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after acquiring an additional 14 shares during the last quarter. Hedge funds and other institutional investors own 94.23% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.